Puma Biotechnology (PBYI) Trading Down 0% Following Analyst Downgrade

Puma Biotechnology logo Puma Biotechnology Inc (NASDAQ:PBYI) traded down 0% during trading on Friday after Barclays lowered their price target on the stock from $92.00 to $90.00. Barclays currently has an overweight rating on the stock. Puma Biotechnology traded as low as $61.55 and last …